Bibliography
- THIEL KA: A very firm handshake: biotech's growing negotiating power. Nat. Biotechnol. (2005) 23:1221-1226.
- BOOTH BL: Early stage returns? Nat. Biotechnol. (2006) 24:1335-1340.
- MAYBECK V, BAINES W: Small company mergers-good for whom? Nat. Biotechnol. (2006) 24:1343-1348.
- LAWRENCE S: Upward trend in financing continues, but fewer feel flush. Nat. Biotechnol. (2007) 25:3.
- CUATRECASAS P: Drug discovery in jeopardy. J. Clin. Invest. (2006) 116:2837-2842.
- BERNAL L: Why pharma must go Hollywood. Scientist (2007) 21:42-47.
- GALLAGHER R: A prescription for pharm. Scientist (2006) 20:13.
- STRUPP D: The investment banker's view. Nat. Biotechnol. (2006) 24:263-264.
- WHALEN J: Small companies seek to profit from drug giants’ castoffs. Wall Street J. (2007) 7 February.
- FRIEDMAN TL: The World is Flat. Farrar, Starus and Giroux, 19 Union Square West, New York, NY, USA (2005).
- GIRIDHARADAS A: India's edge goes beyond outsourcing. The New York Times (2007) 4 April.
- NO AUTHORS LISTED: Life support for life science innovation? Nat. Biotechnol. (2007) 25:144.
- US Government Accountability Office: New drug development. Science, business, and intellectual property issues cited as hampering drug development efforts, GAO-07-49, November (2007).
Website
- http://www.forbes.com/2007/01/19/ pfizer-pharma-cuts-fda-biz-cz_mh_0122pfizer_print.html Herper M: Big pharma's black hole. Forbes (22 January 2007).